Kisner Daniel L - Jun 11, 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role: Director
Signature: Daniel L. Kisner, M.D., by /s/ Trevor Dutcher, Attorney-in-Fact
Stock symbol: DVAX
Transactions as of: Jun 11, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/13/2025, 05:53 PM
Previous filing: Jun 24, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
KISNER DANIEL L	Director	C/O DYNAVAX TECHNOLOGIES, 2100 POWELL STREET, SUITE 720, EMERYVILLE	Daniel L. Kisner, M.D., by /s/ Trevor Dutcher, Attorney-in-Fact	2025-06-13	0001073407

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DVAX	Common Stock	Award	$0	+5.76K	+32.77%	$0.00	23.3K	Jun 11, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DVAX	Stock Option (Right to Buy)	Award	$0	+28.5K		$0.00	28.5K	Jun 11, 2025	Commont Stock	28.5K	$10.18	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company.
F2	This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.

Content

These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company.

This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.